243 related articles for article (PubMed ID: 9525448)
21. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen.
Darnell R; Pecoud A; Richards DH
Clin Exp Allergy; 1994 Dec; 24(12):1144-50. PubMed ID: 7889428
[TBL] [Abstract][Full Text] [Related]
22. Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma.
Ying S; Humbert M; Meng Q; Pfister R; Menz G; Gould HJ; Kay AB; Durham SR
J Allergy Clin Immunol; 2001 Apr; 107(4):686-92. PubMed ID: 11295659
[TBL] [Abstract][Full Text] [Related]
23. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
[TBL] [Abstract][Full Text] [Related]
24. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate.
Meltzer EO; Orgel HA; Rogenes PR; Field EA
J Allergy Clin Immunol; 1994 Oct; 94(4):708-15. PubMed ID: 7930304
[TBL] [Abstract][Full Text] [Related]
25. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Rak S; Heinrich C; Scheynius A
Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
[TBL] [Abstract][Full Text] [Related]
27. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.
Pullerits T; Praks L; Ristioja V; Lötvall J
J Allergy Clin Immunol; 2002 Jun; 109(6):949-55. PubMed ID: 12063523
[TBL] [Abstract][Full Text] [Related]
29. [The effect of fluticasone propionate topically dosed prior to the pollen scattering season on cellular infiltration into the surface of nasal mucous membrane in patients with Japanese cedar pollinosis].
Onishi M; Suihou X; Okubo K; Ikeda M; Yokoshima K; Okuda M
Arerugi; 1993 Mar; 42(3 Pt 1):228-35. PubMed ID: 8498894
[TBL] [Abstract][Full Text] [Related]
30. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ
Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
[TBL] [Abstract][Full Text] [Related]
31. Double-blind comparison of intranasal fluticasone propionate, 200 micrograms, once daily with 200 micrograms twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed.
Dolovich J; O'Connor M; Stepner N; Smith A; Sharma RK
Ann Allergy; 1994 May; 72(5):435-40. PubMed ID: 8179230
[TBL] [Abstract][Full Text] [Related]
32. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology.
Meltzer EO; Orgel HA; Bronsky EA; Furukawa CT; Grossman J; LaForce CF; Lemanske RF; Paull BD; Pearlman DS; Ratner PH
J Allergy Clin Immunol; 1990 Aug; 86(2):221-30. PubMed ID: 2200821
[TBL] [Abstract][Full Text] [Related]
33. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
[TBL] [Abstract][Full Text] [Related]
34. Nasal cytological changes following pharmacological intervention.
Meltzer EO
Allergy; 1995; 50(23 Suppl):15-20. PubMed ID: 7604949
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
[TBL] [Abstract][Full Text] [Related]
36. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents.
LaForce CF; Dockhorn RJ; Findlay SR; Meltzer EO; Nathan RA; Stricker W; Weakley S; Field EA; Rogenes PR
J Fam Pract; 1994 Feb; 38(2):145-52. PubMed ID: 8308505
[TBL] [Abstract][Full Text] [Related]
37. Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis.
Takhar P; Smurthwaite L; Coker HA; Fear DJ; Banfield GK; Carr VA; Durham SR; Gould HJ
J Immunol; 2005 Apr; 174(8):5024-32. PubMed ID: 15814733
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of nasal mucosal eotaxin in patients with allergic rhinitis during grass pollen season: effect of a local glucocorticoid.
Pullerits T; Lindén A; Praks L; Cardell LO; Lötvall J
Clin Exp Allergy; 2000 Oct; 30(10):1469-75. PubMed ID: 10998025
[TBL] [Abstract][Full Text] [Related]
39. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
